Intracellular trafficking of shiga-toxin-B-subunit-functionalized spherulites

Biology of the Cell

Volumn 100, Issue 12, 2008, Pages 717-728

  Bouter, Anthony ^a,b,c   Delord, Brigitte ^a,b   Dransart, Estelle ^d,e   Poirier, Cécile ^a,b   Johannes, Ludger ^d,e   van Effentere, Damien ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE DE RECHERCHE PAUL PASCAL   (France)

^c CNRS   (France)

^d INSTITUT CURIE   (France)

^e CNRS   (France)

Author keywords

Bacterial protein toxin; Drug delivery; Intracellular trafficking; Retrograde transport; Shiga toxin B subunit; Spherulite

Indexed keywords

GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPID; LIGAND; LIPID; SHIGA TOXIN; SHIGA TOXIN B; UNCLASSIFIED DRUG; CERAMIDE TRIHEXOSIDE; SHIGA TOXIN 2 B SUBUNIT; VEROTOXIN 2;

ARTICLE; CELL ADHESION; CELL MEMBRANE; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOSOME; HELA CELL; HUMAN; HUMAN CELL; LIPID VESICLE; LYSOSOME; PRIORITY JOURNAL; SPHERULITE; GENETICS; METABOLISM; PROTEIN TRANSPORT; TRANSPORT VESICLE;

BACTERIA (MICROORGANISMS);

CELL MEMBRANE; HELA CELLS; HUMANS; LYSOSOMES; MICROSCOPY, CONFOCAL; PROTEIN TRANSPORT; SHIGA TOXIN 2; TRANSPORT VESICLES; TRIHEXOSYLCERAMIDES;

EID: 58149345851     PISSN: 02484900     EISSN: 1768322X     Source Type: Journal    
DOI: 10.1042/BC20080009     Document Type: Article

References (42)

1. Abe, A., Inokuchi, J., Jimbo, M., Shimeno, H., Nagamatsu, A., Shayman, J. A., Shukla, G. S. and Radin, N. S. (1992) Improved inhibitors of glucosylceramide synthase. J. Biochem. 111, 191-196
2. Allen, T. and Cullis, P. (2004) Drug delivery systems: entering the mainstream. Science 303, 1818-1822
3. Bonifacino, J. S. and Rojas, R. (2006) Retrograde transport from endosomes to the trans-Golgi network. Nat. Rev. Mol. Cell Biol. 7, 568-579
4. Chenevier, P., Delord, B., Amedee, J., Bareille, R., Ichas, F. and Roux, D. (2002) RGD-functionalized spherulites™ as targeted vectors captured by adherent cultured cells. Biochim. Biophys. Acta 1593, 17-27
5. Chenevier, P., Bourel-Bonnet, L. and Roux, D. (2003) Grafting molecular addresses onto biological vectors by α-oxohydrazone ligation: chemical characterisation and biological efficiency. J. Am. Chem. Soc. 125, 16261-16271
6. + T cells and enhances protective antitumor immunity. Int. J. Cancer 120, 1942-1950
7. Decaudin, D., Castedo, M., Nemati, F., Beurdeley-Thomas, A., De Pinieux, G., Caron, A., Pouillart, P., Wijdenes, J., Rouillard, D., Kroemer, G. and Poupon, M. F. (2002) Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res. 62, 1388-1393
8. Dhanikula, A. B., Lafleur, M. and Leroux, J. C. (2006) Characterization and in vitro evaluation of spherulites as sequestering vesicles with potential application in drug detoxification. Biochim. Biophys. Acta 1758, 1787-1796
9. Douaihy, C. M., Koka, V., Mingotaud, C. and Gauffre, F. (2006) Tunable sustained release properties of 'onion-like' phospholipids multilamellar vesicles. J. Colloid Interface Sci. 303, 280-287
10. El Alaoui, A., Schmidt, F., Amessou, M., Sarr, M., Decaudin, D., Florent, J. C. and Johannes, L. (2007) Shiga toxin-mediated retrograde delivery of a topoisomerase I inhibitor prodrug. Angew Chem. Int. Ed. Engl. 46, 6469-6472
11. Falguières, T., Mallard, F., Baron, C. L., Hanau, D., Lingwood, C., Goud, B., Salamero, J. and Johannes, L. (2001) Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent resistant membranes. Mol. Biol. Cell 12, 2453-2468
12. Fretz, M. M., Mastrobattista, E., Koning, G. A., Jiskoot, W. and Storm, G. (2005) Strategies for cytosolic delivery of liposomal macromolecules. Int. J. Pharm. 298, 305-309
13. Freund, O., Amedee, J., Roux, D. and Laversanne, R. (2000) In vivo and in vitro stability of new multilamellar vesicles. Life Sciences 67, 411-419
14. Gariepy, J. (2001) The use of Shiga-like toxin 1 in cancer therapy. Crit. Rev. Oncol. Hematol. 39, 99-106
15. Gaubert, S., Delord, B., Amedee, J., Boyer, E., Auriault, C., Roux, D. and Laversanne, R. (2005) Amplification of antibody response to antigen using small multilamellar vesicles as delivery systems. Drug Deliv. 12, 1-6
16. Genty, M., Couarraze, G, Laversanne, R., Degert, C., Maccario, J. and Grossiord, J. L. (2003) Complex dispersion of multilamellar vesicles: a promising new carrier for controlled release and protection of encapsulated molecules. J. Control. Release 90, 119-133
17. Haicheur, N., Bismuth, E., Bosset, S., Adotevi, O., Warnier, G., Lacabanne, V., Regnault, A., Desaymard, C., Amigorena, S., Riccardi-Castagnoli, P., Goud, B., Fridman, W. H., Johannes, L. and Tartour, E. (2000) The B-subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I restricted presentation of peptides derived from exogenous antigens. J. Immunol. 165, 3301-3308
18. Janssen, K.-P., Vignjevic, D., Boisgard, R., Falguières, T., Bousquet, G., Decaudin, D., Dollé, F., Louvard, D., Tavitian, B., Robine, S. and Johannes, L. (2006) In vivo tumor targeting using novel intestinal pathogen-based delivery approach. Cancer Res. 66, 7230-7236
19. Johannes, L. and Goud, B. (1998) Surfing on a retrograde wave: how does Shiga toxin reach the endoplasmic reticulum? Trends Cell Biol. 8, 158-162
20. Johannes, L. and Decaudin, D. (2005) Protein toxins: intracellular trafficking for targeted therapy. Gene Ther. 16, 1360-1368
21. Johannes, L., Tenza, D., Antony, C. and Goud, B. (1997) Retrograde transport of KDEL-bearing B-fragment of Shiga toxin. J. Biol. Chem. 272, 19554-19561
22. Kaneda, Y. (2000) Virosomes: evolution of the liposome as a targeted drug delivery system. Adv. Drug Deliv. Rev. 43, 197-205
23. Karanth, H. and Murthy, R. S. (2007) pH-Sensitive liposomesprinciple and application in cancer therapy. J. Pharm. Pharmacol. 59, 469-483
24. Lauvrak, S. U., Torgersen, M. L. and Sandvig, K. (2004) Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin. J. Cell Sci. 117, 2321-2331
25. Lingwood, C. A., Law, H., Richardson, S., Petric, M., Brunton, J. L., De Grandis, S. and Karmali, M. (1987) Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262, 8834-8839
26. Lord, J. M., Deeks, E., Marsden, C. J., Moore, K., Pateman, C., Smith, D. C., Spooner, R. A., Watson, P. and Roberts, L. M. (2003) Retrograde transport of toxins across the endoplasmic reticulum membrane. Biochem. Soc. Trans. 31, 1260-1262
27. Mallard, F., Antony, C., Tenza, D., Salamero, J., Goud, B. and Johannes, L. (1998) Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of Shiga toxin B-fragment transport. J. Cell Biol. 143, 973-990
28. Mao, C. P., Hung, C. F. and Wu, T. C. (2007) Immunotherapeutic strategies employing RNA interference technology for the control of cancers. J. Biomed. Sci. 14, 15-29
29. Mignet, N., Brun, A., Degert, C., Delord, B., Roux, D., Héléne, C., Laversanne, R. and François, J. C. (2000) The spherulites: a promising carrier for oligonucleotide delivery. Nucleic Acids Res. 28, 3134-3142
30. O'Brien, A. D., Tesh, V. L., Donohue-Rolfe, A., Jackson, M. P., Olsnes, S., Sandvig, K., Lindberg, A. A. and Keusch, G. T. (1992) Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr. Top. Microbiol. Immunol. 180, 65-94
31. Olea, D. and Faure, C. (2003) Quantitative study of the encapsulation of glucose oxidase into multilamellar vesicles and its effects on enzyme activity. J. Chem. Phys. 119, 6111-6119
32. Poirier, C., van Effenterre, D., Delord, B., Johannes, L. and Roux, D. (2008) Specific adsorption of functionalized colloids at the surface of living cells: a quantitative kinetic analysis of the receptor-mediated binding. Biochim. Biophys. Acta 1778, 2450-2457
33. Römer, W., Berland, L., Chambon, V., Gaus, K., Windschiegl, B., Tenza, D., Aly, M. R., Fraisier, V., Florent, J.-C., Perrais, D., Lamaze, C., Raposo, G., Steinem, C., Sens, P., Bassereau, P. and Johannes, L. (2007) Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 450, 670-675
34. Roux, D., Chenevier, P., Pott, T., Navailles, L., Regev, O. and Mondain Monval, O. (2004) Conception and realization of a non cationic non viral DNA vector. Curr. Med. Chem. 10, 1241-1253
35. Saint-Pol, A., Yélamos, B., Amessou, M., Mills, I. G., Dugast, M., Tenza, D., Schu, P., Antony, C., McMahon, H. T., Lamaze, C. and Johannes, L. (2004) Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes. Dev. Cell 6, 525-538
36. Sandvig, K. and van Deurs, B. K. (2005) Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther. 12, 865-872
37. Sandvig, K., Olsnes, S., Brown, J. E., Petersen, O. W. and van Deurs, B. (1989) Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. J. Cell Biol. 108, 1331-1343
38. Schoen, P., Chonn, A., Cullis, P. R., Wilschut, J. and Scherrer, P. (1999) Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles. Gene Ther. 6, 823-832
39. Smith, D. C., Lord, J. M., Roberts, L. M., Tartour, E. and Johannes, L. (2002) 1st class ticket to class I: protein toxin as pathfinders for antigen presentation. Traffic 3, 697-704
40. Strockbine, N. A., Marques, L. R., Holmes, R. K. and O'Brien, A. D. (1985) Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect. Immun. 50, 695-700
41. Torchilin, V. P. (2006) Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu. Rev. Biomed. Eng. 8, 343-375
42. Vance, J. E., Campenot, R. B. and Vance, D. E. (2000) The synthesis and transport of lipids for axonal growth and nerve regeneration. Biochim. Biophys. Acta 1486, 84-96